CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention

Figure 2

Kaplan-Meier survival analysis for disease-free and overall survival time.

(a)

(b)

(c)

(d)